Urinary Tract Infection Bacterial Clinical Trial
Official title:
A Phase I/II Study of Bacteriophage Therapy to Evaluate Safety, Tolerability, and Efficacy of Targeted "Personalized" Bacteriophage Treatments in Patients With Bacterial Infection of the Urinary Tract
This is a phase I/II trial designed to evaluate bacteriophage therapy in patients with urinary tract infections.
This study will evaluate the safety and efficacy of bacteriophage therapy in patients with urinary tract infection (UTI). Patients to be enrolled will have urinary tract infections due to E. coli and K. pneumoniae. This will include asymptomatic patients with neurogenic bladder and symptomatic patients with complicated urinary tract infections who are at risk of UTI recurrence. Patients will be followed for bacterial clearance or recurrence of urinary tract infection. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02543827 -
Evaluation of the Efficacy and Safety of MV140
|
Phase 3 | |
| Recruiting |
NCT04291768 -
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
|
Phase 4 | |
| Recruiting |
NCT05667207 -
Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)
|
N/A | |
| Completed |
NCT04671290 -
Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae
|
||
| Completed |
NCT03774940 -
Blood Parameters as a Predictor of Fever After Percutaneous Nephrolithotomy
|
N/A | |
| Completed |
NCT03801213 -
Evaluation of Urine Samples Obtained by Bladder Stimulation for the Diagnosis of Urinary Tract Infection in Infants
|
N/A | |
| No longer available |
NCT04173013 -
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
|